bioAffinity closes $4 million registered direct financing
bioAffinity Technologies said it closed its previously announced registered direct offering of common stock and a concurrent private placement priced at-the-market under Nasdaq rules.
Story updates
03:37:41 PM UTC
SquawkNews
bioAffinity closed a registered direct offering and concurrent private placement for gross proceeds of approximately $4M, including warrants for up to 980,072 shares at $6.122, with pre-funded warrants at a $0.007 exercise price.Material DetailsContext by AI AnalystThis is an early-stage capital ra…